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1O-Substituted-2-chloro-6a,7 -dihydro-6H-7 -(4-substitu-
ted phenyl)-6-phenyl-[ 1]benzopyrano[3,4-c] [1,5] ben-
zothiazepines 3a-l have been synthesized by reacting
(E)-6-chloro-3-( 4-chloro / methoxybenzylidene ) flava-
nones 2a, b with 5-substituted-2-aminobenzenethiols l a-f
by reflux heating in dry toluene containing piperidine
(1: 1). The products have been tested for purity by TLC
and microestimation of nitrogen. IR and IH NMR and
mass spectral studies have enabled the assignment of
structures. Bioassay screening of 3e,f,h and i show mild
analgesic and anticonvulsant activity.
Compounds having a 1,5-benzothiazepine
nucleus have been found to be chemothera-
peutically useful showing CVS activities, such as
coronary vasodilation I, calcium antagonists', blood
platelet aggregation inhibitors', antiischemics",
antihyper-tensives', antiarrhythmics", etc.
Compared to most widely used 1,5-
benzothiazepine drug, diltiazem", last five years
have witnessed the upsurge of relatively more
effective cardiovascular drug, clentiazem", which
possesses a substituent in the fused benzene ring of
1,5-benzothiazepine nucleus. Incorporation of
additional heterocyclic ring as a pharmacophore in
the 1,5-benzothiazepine nucleus has resulted into
the patented compound of useful bioactivity",
Proceeding on these lines, we reported the
syntheses of compounds having tetracyclic ring







system is fused with benzothiazepine possessing a
substituent in the fused benzene ring of the latter".
In continuation, we report here the syntheses of 10-
subtituted-2-chloro-6a, 7 -dihydro-6H- 7-
(4- substituted phenyl)-6-phenyl-[ I [benzopyrano-
[3,4-c] [1,5]benzothiazepines.
The syntheses of the title compounds were
effected by reacting unsaturated ketones having
a.b-unsaturation exocyclic to carbonyl group i.e.
(E)-6-chloro-3-( 4-chloro/methoxy benzylidene)
flavanones 2a,b with six 5-substituted-2-
aminobenzenethiols where the substituents are
halo-fluoro, chloro, bromo; alkyl-methyl; alkoxyl-
methoxyl and ethoxyl la-f by reflux heating for
nearly 6-20 hr in dry toluene and piperidine (1: 1).
The arylidene flavanones 2a,b were prepared by
acid catalyzed condensation of 6-chloroflavanone
with 4-chlorobenzaldehyde and 4-anisaldehyde
respectively. 6-Chloroflavanone was prepared by
reacting 5-chloro-2-hydroxy acetophenone with
benzaldehyde in ethanol in the presence of 50%
NaOW1•
Compound 2 having an exocyclic double bond
in conjugation with a carbonyl group can exist as
structures having cis- and trans-configuration
(Figure 1). The trans-form is proved by the allylic
coupling constants in the range, 2.1-2.25 Hz in the
proton NMR spectra". A broad singlet at 8 6.9
(2a ),8 7.2:2 (2b) correspond to the methine proton
at C-2 and another broad singlet at 8 7.2 (2a),8
7.42 (2b) correspond to the vinyl proton.
The reaction occurs via nucleophilic attack by
the sulphydryl electrons of thiol group on the vinyl








carbon of arylidene flavanone which is rendered
electrophilic due to vinyl-carbonyl conjugation.
This is followed by condensation reaction between
the amino group of the thiol and the carbonyl
group resulting into the formation of final cyc1yzed
product (dehydrative cyclization), benzopyrano-
benzothiazepines (3a-l, Scheme I).
Characterization of 'the products was done on
the basis of analytical (Table-I) and spectral
studies.
Infrared spectra of all compounds 3a-1 showed a
sharp absorption band at 1602-1612 cm' which
may be assigned to C=N stretching frequency of
heterocyclic ring!'. IR of 3e-1 displayed sharp
absorption bands and comparatively weaker ones
in the range, 1230-1200 and 1038-1078 cm'
corresponding to aralkyl etheral linkage. Presence
of chlorine was also observed as one or two sharp
bands at 680-695 and 750-790 cm' Absence of
absorption bands at 1670-1680 (CO) and at 3450-
3350 cm' (NHz) indicated absence of these groups
in the products. The IH NMR spectra of all
compounds showed a number of peaks in the
region, 8 3.6 to 3.9. A doublet at 0 3.85-3.89
(J=12.11-12.21 Hz) may be due to C-7 proton.
Another doublet at 0 3.81-3.84 with J=1.6-1.8 Hz
was assigned to the C-6 proton. A comparatively
weak double doublet absorption at 83.67-3.73 was
assigned to the bridgehead proton at C-6a. Further,
a singlet at 03.84 (3H) corresponding to methoxyl
protons appeared in the spectra of 3g-1. On the
basis of coupling constants, JH•7, H.6a=12.11-12.21
Hz and J H.6,H.6a=1.6-1.8Hz, it is assumed that the
hydrogen atoms at the two adjacent carbon atoms,




It was carried out for four compounds 3e, f, h, i
as given below:
Effect on respiration, cardiovascular system
and nictitating memb-rane contraction. Adult
cats of either sex, anaesthesised with
pentobarbitone sodium (30 mglkg i.v.) were
employed. The trachea was cannulated and
connected to Marey's tambour, one of the common
carotid arteries, was cannulated and connected to a
mercury monometer. Records were made on a slow
moving kymograph. The compounds were
administered through a cannulated femoral vein.
Each compound was administered in doses of 1
and 5 mglkg i.v. Effect on respiration was assessed
on rate and amplitude. The effect on blood
pressure was studied from the common carotid
artery through an indwelling cannula on a
kymograph. The effect of the compounds was
observed on the blood pressure per se and also on
the blood pressure responses of adrenaline (2-4
ug), acetylcholine (1-2 ug), histamine (1-2 ug) and
isoprenaline (1-2 ug). The contraction of one of
the nictitating membranes, due to electrical
stimulation of sympathetic nerve, was also
recorded through a system of pulleys and frontal
writing level on the kymograph.
Gross effects and effects on central nervous
system. These were studied in mice of either sex
between 15 and 20 g. Initial testing was done at
100 mglkg dose using 5 animals. Gross effects
were observed for 2 hrs after drug administration
for any evidence of CNS stimulation or depression
or any autonomic effect. This involved noting the
effect on (i) spontaneous motor activity, (ii) certain
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Table 1- Physical constants and microanalytical data of 10-substituted-2-chloro-6a,7-dihydro-6H-7-(4-substituted phenyl)-6-
phenyl-] I ]benzo-pyrano[3,4-c][ 1,5]benzothiazepines 3a-1
Compd.3 R X Mol Formula m.p. Yield N analysis
[M]+,[M+2r caC) (%) (%)Found
(Caled.)
a CI F C2sH,sNSOFC12.(505,507) 110-115 45 2.80 (2.79)
b CI CI C2sHISNSOCIJ 132-136 45 2.72 (2.70)
c CI Br CzsH,sNSOC12Br 110 50 2.51 (2.49)
d CI CHJ CZ9HzINSOCI2 108 67 2.83 (2.81)
e CI OCHJ CZ9HzINSOzClz 82 61 2.75 (2.73)
f Cl OCzHs CJoHnNSOzCI2 ,(531 ,533) 85 62 2.66 (2.65)
g OCHJ F Cz9H2INSOzFCI, (501,503) 88 58 2.79 (2.77)
h OCHJ CI CZ9HzINSOzCI2 120 65 2.70 (2.68)
I OCHJ Br C29Hz,NS02ClBr 88 50 2.50 (2.47)
j OCHJ OCHJ CJOHZ4NSOzCI, (497,499) 118 62 2.78 (2.80)
k OCHJ OCHJ CJOHZ4NSOJCI 72 59 2.72 (2.70)
I OCHJ OCzHs CJ,H26NSOJCl, (527,529) 88 63 2.67 (2.65)
reflexes e.g. writhing, corneal or pinnal, (iii)
muscletone (reduced and catalepsy), (iv) posture
and gait (ataxia and writhing), (v) eyes (pupil and
ptosis), (vi) respiration and (vii) observing them
for occurrence of tremors, convulsions, Straub's
tail, piloerection, cyanosis and body temperature.
Analgesic screening was carried out by
Haffner's Tail Clip Method'4. Failure to produce
the painful vocalization and self biting of the tails
indicates the analgesic activity. The Supramaximal
Electroshock Seizure Pattern Test was carried out
by delivering a current stimulus of 48 mA through
an electroconvulsiometer using ear electrodes. In
saline treated controls, it produces tonic extension
of the hind limbs. Block of convulsions indicates
anticonvulsant activity.
However, none of the four compounds (3e, 3r,
3h and 3i; Table-I) exhibited any marked activity
for further follow-up studies.
Experimental Section
Melting points are uncorrected. IR spectra were
recorded in KBr pellets on a Perkin Elmer
Infracord 881 spectrophotometer, PMR spectra in
CDCl3 on a Jeol FT NMR 400 MHz spectrometer
using TMS as internal standard and mass spectra
on a varian Match-7 instrument at 70 ev. Burity of
the compounds was checked by TLC on silica gel
'G' coated glass plates using toluene: ethyl acetate
(7:3) as irrigant.
5-chloro-2-hydroxyacetophenone'5 and 5-
substituted-2-aminobenzenethiols 16 were prepared
by literature methods.
6-chloro-3-( 4-substituted-benzylidene) flava-
none 2. Equimolar quantities of 6-chloroflavanone
(0.01 mole, 2.575 g) and 4-chlorobenzaldehyde/4-
methoxybenzaldehyde (0.01 mole, l.405/l.36 g)
were dissolved in dry ethanol (50 mL). To this
reaction mixture, hydrogen chloride gas was
passed with gentle heating and stirring till the
colour of the reaction mixture changed from
yellow to dark red. The reaction mixture was kept
at room temperature for 24 hr and crystallization of
the crude solid from dry methanol afforded the
arylidene flavanone, 6-chloro-3-( 4-chloro
benzylidene) flavanone 2a, yellow crystals, m.p.
128-3-Q°C, yield 2.48 g (65%) and 6-chloro-3-(4-
methoxy-benzylidene) flavanone 2b, pinkish
brown amorphous solid, m.p. 85°C, yield 2.11 g
(56%).
10-Ethoxy-2-chloro-6a, 7-dihydro-6I/- 7-( 4-
methoxyphenyl)-6-phenyl-[I]benzopyrano [3, 4-
c] [1,5] benzothiazepines 31. 2-Amino-5-
ethoxybenzenethiol (0.001 mole, 0.169 g) and 6-
chloro- 3-(4-methoxy benzy Iidene) flavanone
(0.001 mole, 0.376 g) were taken in dry toleune (5
mL) containing dry piperidine (5 mL). The
reaction mixture was refluxed for 22 hrs till one of
the reactants disappeared which was noticed by tlc
monitoring. Solvent was removed to obtain an
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amorphous solid which was crystallized from dry
methanol, yield 0.30 g (58%), m.p. 88°C, [TLC R,
0.92]; (Found: N, 2.67%. C31H26NS03C1requires N
2.65%); MS : m/z [Mr 527, [M+2r 529; PMR :8
1.49 (t, 3H, J= 6 Hz), 4.12 (q, 2H, J= 6Hz), C-10-
OC2H5], 3.73 (dd, 1H, H-6a), 3.83 (d, 1H, J=1.8Hz,
H-6), 3.87 (d, 1H, J = 12.12 Hz, H-7), 3.84 (3H, s,
OCH3), 6.85-8.08 (m, 15 H, ArH).
Similarly 3a-k were prepared. However, 3a-f
required refluxing for 6-10 hrs whereas 3g-k, for
20-22 hr.
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